Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Biomarker-Directed Therapy in Metastatic Colorectal Cancer
    Release Date:
    Partner: The National Comprehensive Cancer Network®, Fight Colorectal Cancer
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory Conditions
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada
    Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Rare Disease Canada
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Improving Treatment Environment and Survivorship for Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Improving Treatment Environment and Survivorship for Leukemia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Advances in the Management of Ulcerative Colitis (UC) (Europe, Canada, Japan, South Korea, Australia, New Zealand, Israel)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Increasing Awareness and Understanding of Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Shared Decision-Making (SDM) for Patient Quality of Life in Cancer Treatment and Improving Access to Biologics
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Improvement of Treatment Environment of Immuno-Oncology Therapy for Urothelial Cancer
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Japan
    Optimizing the management of mBC HER2-patients / Oncology
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy